title: 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran). A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
authors.forename: L Samuel
authors.initials: LS
authors.lastname: Wann
authors.forename: Anne B
authors.initials: AB
authors.lastname: Curtis
authors.forename: Kenneth A
authors.initials: KA
authors.lastname: Ellenbogen
authors.forename: N A Mark
authors.initials: NA
authors.lastname: Estes
authors.forename: Michael D
authors.initials: MD
authors.lastname: Ezekowitz
authors.forename: Warren M
authors.initials: WM
authors.lastname: Jackman
authors.forename: Craig T
authors.initials: CT
authors.lastname: January
authors.forename: James E
authors.initials: JE
authors.lastname: Lowe
authors.forename: Richard L
authors.initials: RL
authors.lastname: Page
authors.forename: David J
authors.initials: DJ
authors.lastname: Slotwiner
authors.forename: William G
authors.initials: WG
authors.lastname: Stevenson
authors.forename: Cynthia M
authors.initials: CM
authors.lastname: Tracy
authors.forename: Valentin
authors.initials: V
authors.lastname: Fuster
authors.forename: Lars E
authors.initials: LE
authors.lastname: Rydén
authors.forename: David S
authors.initials: DS
authors.lastname: Cannom
authors.forename: Harry J
authors.initials: HJ
authors.lastname: Crijns
authors.forename: Anne B
authors.initials: AB
authors.lastname: Curtis
authors.forename: Kenneth A
authors.initials: KA
authors.lastname: Ellenbogen
authors.forename: Jonathan L
authors.initials: JL
authors.lastname: Halperin
authors.forename: G Neal
authors.initials: GN
authors.lastname: Kay
authors.forename: Jean-Yves
authors.initials: JY
authors.lastname: Le Heuzey
authors.forename: James E
authors.initials: JE
authors.lastname: Lowe
authors.forename: S Bertil
authors.initials: SB
authors.lastname: Olsson
authors.forename: Eric N
authors.initials: EN
authors.lastname: Prystowsky
authors.forename: Juan Luis
authors.initials: JL
authors.lastname: Tamargo
authors.forename: L Samuel
authors.initials: LS
authors.lastname: Wann
authors.forename: Alice K
authors.initials: AK
authors.lastname: Jacobs
authors.forename: Jeffrey L
authors.initials: JL
authors.lastname: Anderson
authors.forename: Nancy
authors.initials: N
authors.lastname: Albert
authors.forename: Mark A
authors.initials: MA
authors.lastname: Creager
authors.forename: Steven M
authors.initials: SM
authors.lastname: Ettinger
authors.forename: Robert A
authors.initials: RA
authors.lastname: Guyton
authors.forename: Jonathan L
authors.initials: JL
authors.lastname: Halperin
authors.forename: Judith S
authors.initials: JS
authors.lastname: Hochman
authors.forename: Frederick G
authors.initials: FG
authors.lastname: Kushner
authors.forename: Erik Magnus
authors.initials: EM
authors.lastname: Ohman
authors.forename: William G
authors.initials: WG
authors.lastname: Stevenson
authors.forename: Clyde W
authors.initials: CW
authors.lastname: Yancy
mesh_terms: D001281:Atrial Fibrillation / Q000188:drug therapy*; D001562:Benzimidazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D000069604:Dabigatran; D019317:Evidence-Based Medicine; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D015091:beta-Alanine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D001562:Benzimidazoles; D005343:Fibrinolytic Agents; D015091:beta-Alanine; D000069604:Dabigatran